| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $4.9B | $3.6B | $2.8B | $2.2B | $1.9B |
| Cost of Revenue | $1.1B | $0.8B | $0.6B | $0.5B | $0.5B |
| Gross Profit | — | — | — | — | — |
| R&D Expense | $1.6B | $1.4B | $1.3B | $0.9B | $0.5B |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $-1.2B | $-1.1B | $-1.3B | $-0.9B | $-0.5B |
| Net Income | $-1.1B | $-0.9B | $-1.2B | $-0.9B | $-0.5B |
| EPS (Basic) | $-1.54 | $-1.44 | $-1.87 | $-1.55 | $-0.97 |
| EPS (Diluted) | $-1.54 | $-1.44 | $-1.87 | $-1.55 | $-0.97 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $9.6B | $7.2B | $6.2B | $5.4B | $4.6B |
| Current Assets | $4.9B | $3.7B | $3.3B | $3.8B | $3.7B |
| Cash & Equivalents | $1.2B | $0.7B | $0.7B | $3.0B | $3.0B |
| Total Liabilities | $9.2B | $7.0B | $6.1B | $5.1B | $4.0B |
| Current Liabilities | $5.1B | $3.7B | $3.1B | $2.5B | $2.2B |
| Stockholders' Equity | $0.4B | $0.2B | $0.1B | $0.3B | $0.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $0.8B | $0.5B | $0.4B | $0.7B |
| Investing Cash Flow | $-1.4B | $-0.9B | $-2.8B | $-0.4B | $-0.1B |
| Capital Expenditures | $0.4B | $0.2B | $0.3B | $0.4B | $0.1B |
| Financing Cash Flow | $0.1B | $0.1B | $0.1B | $0.0B | $1.6B |